Skip to main content
Top
Published in: BMC Immunology 1/2012

Open Access 01-12-2012 | Research article

The peritoneal macrophage inflammatory profile in cirrhosis depends on the alcoholic or hepatitis C viral etiology and is related to ERK phosphorylation

Authors: Ana Tapia-Abellán, María Martínez-Esparza, Antonio J Ruiz-Alcaraz, Trinidad Hernández-Caselles, Cristina Martínez-Pascual, Manuel Miras-López, José Such, Rubén Francés, Pilar García-Peñarrubia

Published in: BMC Immunology | Issue 1/2012

Login to get access

Abstract

Background

The development of ascites in cirrhotic patients generally heralds a deterioration in their clinical status. A differential gene expression profile between alcohol- and hepatitis C virus (HCV)-related cirrhosis has been described from liver biopsies, especially those associated with innate immune responses. The aim of this work was to identify functional differences in the inflammatory profile of monocyte-derived macrophages from ascites in cirrhotic patients of different etiologies in an attempt to extrapolate studies from liver biopsies to immune cells in ascites. To this end 45 patients with cirrhosis and non-infected ascites, distributed according to disease etiology, HCV (n = 15) or alcohol (n = 30) were studied. Cytokines and the cell content in ascites were assessed by ELISA and flow cytometry, respectively. Cytokines and ERK phosphorylation in peritoneal monocyte-derived macrophages isolated and stimulated in vitro were also determined.

Results

A different pattern of leukocyte migration to the peritoneal cavity and differences in the primed status of macrophages in cirrhosis were observed depending on the viral or alcoholic etiology. Whereas no differences in peripheral blood cell subpopulations could be observed, T lymphocyte, monocyte and polymorphonuclear cell populations in ascites were more abundant in the HCV than the alcohol etiology. HCV-related cirrhosis etiology was associated with a decreased inflammatory profile in ascites compared with the alcoholic etiology. Higher levels of IL-10 and lower levels of IL-6 and IL-12 were observed in ascitic fluid from the HCV group. Isolated peritoneal monocyte-derived macrophages maintained their primed status in vitro throughout the 24 h culture period. The level of ERK1/2 phosphorylation was higher in ALC peritoneal macrophages at baseline than in HCV patients, although the addition of LPS induced a greater increase in ERK1/2 phosphorylation in HCV than in ALC patients.

Conclusions

The macrophage inflammatory status is higher in ascites of alcohol-related cirrhotic patients than in HCV-related patients, which could be related with differences in bacterial translocation episodes or regulatory T cell populations. These findings should contribute to identifying potential prognostic and/or therapeutic targets for chronic liver diseases of different etiology.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mas VR, Fassnacht R, Archer KJ, Maluf D: Molecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis. Mol Med. 2010, 16: 287-297.PubMedPubMedCentralCrossRef Mas VR, Fassnacht R, Archer KJ, Maluf D: Molecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis. Mol Med. 2010, 16: 287-297.PubMedPubMedCentralCrossRef
2.
go back to reference Chen CM, Yoon YH, Yi HY, Lucas DL: Alcohol and hepatitis C mortality among males and females in the United States: a life table analysis. Alcohol Clin Exp Res. 2007, 31: 285-292. 10.1111/j.1530-0277.2006.00304.x.PubMedCrossRef Chen CM, Yoon YH, Yi HY, Lucas DL: Alcohol and hepatitis C mortality among males and females in the United States: a life table analysis. Alcohol Clin Exp Res. 2007, 31: 285-292. 10.1111/j.1530-0277.2006.00304.x.PubMedCrossRef
3.
go back to reference Wise M, Bialek S, Finelli L, Bell BP, Sorvillo F: Changing trends in hepatitis C-related mortality in the United States, 1995–2004. Hepatology. 2008, 47: 1128-1135.PubMedCrossRef Wise M, Bialek S, Finelli L, Bell BP, Sorvillo F: Changing trends in hepatitis C-related mortality in the United States, 1995–2004. Hepatology. 2008, 47: 1128-1135.PubMedCrossRef
4.
go back to reference Uchimura Y, Sata M, Kage M, Abe H, Tanikawa K: A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease. Liver. 1995, 15: 300-306.PubMedCrossRef Uchimura Y, Sata M, Kage M, Abe H, Tanikawa K: A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease. Liver. 1995, 15: 300-306.PubMedCrossRef
5.
go back to reference Lederer SL, Walters KA, Proll S, Paeper B, Robinzon S, Boix L: Distinct cellular responses differentiating alcohol- and hepatitis C virus-induced liver cirrhosis. Virol J. 2006, 3: 98-10.1186/1743-422X-3-98.PubMedPubMedCentralCrossRef Lederer SL, Walters KA, Proll S, Paeper B, Robinzon S, Boix L: Distinct cellular responses differentiating alcohol- and hepatitis C virus-induced liver cirrhosis. Virol J. 2006, 3: 98-10.1186/1743-422X-3-98.PubMedPubMedCentralCrossRef
6.
go back to reference Miller AM, Horiguchi N, Jeong WI, Radaeva S, Gao B: Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines. Alcohol Clin Exp Res. 2011, 35: 787-793. 10.1111/j.1530-0277.2010.01399.x.PubMedPubMedCentralCrossRef Miller AM, Horiguchi N, Jeong WI, Radaeva S, Gao B: Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines. Alcohol Clin Exp Res. 2011, 35: 787-793. 10.1111/j.1530-0277.2010.01399.x.PubMedPubMedCentralCrossRef
7.
go back to reference McClain CJ, Song Z, Barve SS, Hill DB, Deaciuc I: Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol. 2004, 287: G497-G502. 10.1152/ajpgi.00171.2004.PubMedCrossRef McClain CJ, Song Z, Barve SS, Hill DB, Deaciuc I: Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol. 2004, 287: G497-G502. 10.1152/ajpgi.00171.2004.PubMedCrossRef
8.
go back to reference Heller J, Sogni P, Barriere E, Tazi KA, Chauvelot-Moachon L, Guimont MC: Effects of lipopolysaccharide on TNF-alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis. J Hepatol. 2000, 33: 376-381. 10.1016/S0168-8278(00)80272-X.PubMedCrossRef Heller J, Sogni P, Barriere E, Tazi KA, Chauvelot-Moachon L, Guimont MC: Effects of lipopolysaccharide on TNF-alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis. J Hepatol. 2000, 33: 376-381. 10.1016/S0168-8278(00)80272-X.PubMedCrossRef
9.
go back to reference Frances R, Munoz C, Zapater P, Uceda F, Gascon I, Pascual S: Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites. Gut. 2004, 53: 860-864. 10.1136/gut.2003.027425.PubMedPubMedCentralCrossRef Frances R, Munoz C, Zapater P, Uceda F, Gascon I, Pascual S: Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites. Gut. 2004, 53: 860-864. 10.1136/gut.2003.027425.PubMedPubMedCentralCrossRef
10.
go back to reference Ruiz-Alcaraz AJ, Martinez-Esparza M, Cano R, Hernandez-Caselles T, Recarti C, Llanos L: Peritoneal macrophage priming in cirrhosis is related to ERK phosphorylation and IL-6 secretion. Eur J Clin Invest. 2011, 41: 8-15. 10.1111/j.1365-2362.2010.02368.x.PubMedCrossRef Ruiz-Alcaraz AJ, Martinez-Esparza M, Cano R, Hernandez-Caselles T, Recarti C, Llanos L: Peritoneal macrophage priming in cirrhosis is related to ERK phosphorylation and IL-6 secretion. Eur J Clin Invest. 2011, 41: 8-15. 10.1111/j.1365-2362.2010.02368.x.PubMedCrossRef
11.
go back to reference Ferri S, Lalanne C, Lanzoni G, Bassi M, Asioli S, Cipriano V: Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C. Dig Liver Dis. 2011, 43: 807-813. 10.1016/j.dld.2011.04.020.PubMedCrossRef Ferri S, Lalanne C, Lanzoni G, Bassi M, Asioli S, Cipriano V: Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C. Dig Liver Dis. 2011, 43: 807-813. 10.1016/j.dld.2011.04.020.PubMedCrossRef
12.
go back to reference Li WY, Jiang YF, Jin QL, Zhang H, Feng XW, Niu JQ: Immunologic characterization of posthepatitis cirrhosis caused by HBV and HCV infection. J Biomed Biotechnol. 2010, 201: 138237- Li WY, Jiang YF, Jin QL, Zhang H, Feng XW, Niu JQ: Immunologic characterization of posthepatitis cirrhosis caused by HBV and HCV infection. J Biomed Biotechnol. 2010, 201: 138237-
13.
go back to reference Lemmers A, Moreno C, Gustot T, Marechal R, Degre D, Demetter P: The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology. 2009, 49: 646-657. 10.1002/hep.22680.PubMedCrossRef Lemmers A, Moreno C, Gustot T, Marechal R, Degre D, Demetter P: The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology. 2009, 49: 646-657. 10.1002/hep.22680.PubMedCrossRef
14.
go back to reference Bonacini M, Govindarajan S, Kohla M, Lai MM, Lindsay KL: Intrahepatic lymphocyte phenotypes in hepatitis C virus infection: a comparison between cirrhotic and non-cirrhotic livers. Minerva Gastroenterol Dietol. 2007, 53: 1-7.PubMed Bonacini M, Govindarajan S, Kohla M, Lai MM, Lindsay KL: Intrahepatic lymphocyte phenotypes in hepatitis C virus infection: a comparison between cirrhotic and non-cirrhotic livers. Minerva Gastroenterol Dietol. 2007, 53: 1-7.PubMed
15.
go back to reference Ribera J, Pauta M, Melgar-Lesmes P, Tugues S, Fernandez-Varo G, Held KF: Increased nitric oxide production in lymphatic endothelial cells causes impairment of lymphatic drainage in cirrhotic rats. Gut. 2012, in press. doi: gutjnl-2011-300703 Ribera J, Pauta M, Melgar-Lesmes P, Tugues S, Fernandez-Varo G, Held KF: Increased nitric oxide production in lymphatic endothelial cells causes impairment of lymphatic drainage in cirrhotic rats. Gut. 2012, in press. doi: gutjnl-2011-300703
16.
go back to reference Zimmermann HW, Seidler S, Nattermann J, Gassler N, Hellerbrand C, Zernecke A: Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS One. 2010, 5: e11049-10.1371/journal.pone.0011049.PubMedPubMedCentralCrossRef Zimmermann HW, Seidler S, Nattermann J, Gassler N, Hellerbrand C, Zernecke A: Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS One. 2010, 5: e11049-10.1371/journal.pone.0011049.PubMedPubMedCentralCrossRef
17.
go back to reference Zimmermann HW, Seidler S, Gassler N, Nattermann J, Luedde T, Trautwein C: Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS One. 2011, 6: e21381-10.1371/journal.pone.0021381.PubMedPubMedCentralCrossRef Zimmermann HW, Seidler S, Gassler N, Nattermann J, Luedde T, Trautwein C: Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS One. 2011, 6: e21381-10.1371/journal.pone.0021381.PubMedPubMedCentralCrossRef
18.
go back to reference Delhem N, Cottrez F, Carpentier A, Miroux C, Morales O, Francois V: Role of the regulatory T lymphocytes in hepatitis C fibrosis progression. Bull Cancer. 2008, 95: 1029-1038.PubMed Delhem N, Cottrez F, Carpentier A, Miroux C, Morales O, Francois V: Role of the regulatory T lymphocytes in hepatitis C fibrosis progression. Bull Cancer. 2008, 95: 1029-1038.PubMed
19.
20.
go back to reference Sreenarasimhaiah J, Jaramillo A, Crippin J, Lisker-Melman M, Chapman WC, Mohanakumar T: Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis. Hum Immunol. 2003, 64: 224-230. 10.1016/S0198-8859(02)00781-4.PubMedCrossRef Sreenarasimhaiah J, Jaramillo A, Crippin J, Lisker-Melman M, Chapman WC, Mohanakumar T: Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis. Hum Immunol. 2003, 64: 224-230. 10.1016/S0198-8859(02)00781-4.PubMedCrossRef
21.
go back to reference Lin CY, Tsai IF, Ho YP, Huang CT, Lin YC, Lin CJ: Endotoxemia contributes to the immune paralysis in patients with cirrhosis. J Hepatol. 2007, 46: 816-826. 10.1016/j.jhep.2006.12.018.PubMedCrossRef Lin CY, Tsai IF, Ho YP, Huang CT, Lin YC, Lin CJ: Endotoxemia contributes to the immune paralysis in patients with cirrhosis. J Hepatol. 2007, 46: 816-826. 10.1016/j.jhep.2006.12.018.PubMedCrossRef
22.
go back to reference Dolganiuc A, Garcia C, Kodys K, Szabo G: Distinct Toll-like receptor expression in monocytes and T cells in chronic HCV infection. World J Gastroenterol. 2006, 12: 1198-1204.PubMedPubMedCentral Dolganiuc A, Garcia C, Kodys K, Szabo G: Distinct Toll-like receptor expression in monocytes and T cells in chronic HCV infection. World J Gastroenterol. 2006, 12: 1198-1204.PubMedPubMedCentral
23.
go back to reference Mozer-Lisewska I, Sluzewski W, Kaczmarek M, Jenek R, Szczepanski M, Figlerowicz M: Tissue localization of Toll-like receptors in biopsy specimens of liver from children infected with hepatitis C virus. Scand J Immunol. 2005, 62: 407-412. 10.1111/j.1365-3083.2005.01670.x.PubMedCrossRef Mozer-Lisewska I, Sluzewski W, Kaczmarek M, Jenek R, Szczepanski M, Figlerowicz M: Tissue localization of Toll-like receptors in biopsy specimens of liver from children infected with hepatitis C virus. Scand J Immunol. 2005, 62: 407-412. 10.1111/j.1365-3083.2005.01670.x.PubMedCrossRef
24.
go back to reference Seki E, Brenner DA: Toll-like receptors and adaptor molecules in liver disease: update. Hepatology. 2008, 48: 322-335. 10.1002/hep.22306.PubMedCrossRef Seki E, Brenner DA: Toll-like receptors and adaptor molecules in liver disease: update. Hepatology. 2008, 48: 322-335. 10.1002/hep.22306.PubMedCrossRef
25.
go back to reference Such J, Runyon BA: Spontaneous bacterial peritonitis. Clin Infect Dis. 1998, 27: 669-674. 10.1086/514940.PubMedCrossRef Such J, Runyon BA: Spontaneous bacterial peritonitis. Clin Infect Dis. 1998, 27: 669-674. 10.1086/514940.PubMedCrossRef
26.
go back to reference Albillos A, Cuervas-Mons V, Millan I, Canton T, Montes J, Barrios C: Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis. Gastroenterology. 1990, 98: 134-140.PubMed Albillos A, Cuervas-Mons V, Millan I, Canton T, Montes J, Barrios C: Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis. Gastroenterology. 1990, 98: 134-140.PubMed
27.
go back to reference Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995, 273: 117-123. 10.1001/jama.1995.03520260039030.PubMedCrossRef Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995, 273: 117-123. 10.1001/jama.1995.03520260039030.PubMedCrossRef
28.
go back to reference Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996, 334: 693-699. 10.1056/NEJM199603143341104.PubMedCrossRef Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996, 334: 693-699. 10.1056/NEJM199603143341104.PubMedCrossRef
29.
go back to reference Runyon BA: Paracentesis of ascitic fluid. A safe procedure. Arch Intern Med. 1986, 146: 2259-2261. 10.1001/archinte.1986.00360230201029.PubMedCrossRef Runyon BA: Paracentesis of ascitic fluid. A safe procedure. Arch Intern Med. 1986, 146: 2259-2261. 10.1001/archinte.1986.00360230201029.PubMedCrossRef
30.
go back to reference Runyon BA, Canawati HN, Akriviadis EA: Optimization of ascitic fluid culture technique. Gastroenterology. 1988, 95: 1351-1355.PubMed Runyon BA, Canawati HN, Akriviadis EA: Optimization of ascitic fluid culture technique. Gastroenterology. 1988, 95: 1351-1355.PubMed
31.
go back to reference Zapater P, Cano R, Llanos L, Ruiz-Alcaraz AJ, Pascual S, Barquero C: Norfloxacin modulates the inflammatory response and directly affects neutrophils in patients with decompensated cirrhosis. Gastroenterology. 2009, 137: 1669-1679. 10.1053/j.gastro.2009.07.058.PubMedCrossRef Zapater P, Cano R, Llanos L, Ruiz-Alcaraz AJ, Pascual S, Barquero C: Norfloxacin modulates the inflammatory response and directly affects neutrophils in patients with decompensated cirrhosis. Gastroenterology. 2009, 137: 1669-1679. 10.1053/j.gastro.2009.07.058.PubMedCrossRef
32.
go back to reference Simera I, Moher D, Hoey J, Schulz KF, Altman DG: A catalogue of reporting guidelines for health research. Eur J Clin Invest. 2010, 40: 35-53. 10.1111/j.1365-2362.2009.02234.x.PubMedCrossRef Simera I, Moher D, Hoey J, Schulz KF, Altman DG: A catalogue of reporting guidelines for health research. Eur J Clin Invest. 2010, 40: 35-53. 10.1111/j.1365-2362.2009.02234.x.PubMedCrossRef
Metadata
Title
The peritoneal macrophage inflammatory profile in cirrhosis depends on the alcoholic or hepatitis C viral etiology and is related to ERK phosphorylation
Authors
Ana Tapia-Abellán
María Martínez-Esparza
Antonio J Ruiz-Alcaraz
Trinidad Hernández-Caselles
Cristina Martínez-Pascual
Manuel Miras-López
José Such
Rubén Francés
Pilar García-Peñarrubia
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2012
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/1471-2172-13-42

Other articles of this Issue 1/2012

BMC Immunology 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.